cetirizine has been researched along with loratadine in 173 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.58) | 18.7374 |
1990's | 51 (29.48) | 18.2507 |
2000's | 87 (50.29) | 29.6817 |
2010's | 31 (17.92) | 24.3611 |
2020's | 3 (1.73) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Jolliet, P; Morin, C; Morin, D; Pagliara, A; Rihoux, JP; Testa, B; Tillement, JP; Urien, S | 1 |
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Keserü, GM | 1 |
Arrington, MP; Bayless, L; Cai, X; Collart, P; Eckman, JB; Ellis, JL; Ene, DG; Lewis, TA; Libertine, L; Nicolas, JM; Scannell, RT; Wels, BF; Wenberg, K; Wypij, DM; Young, MA | 1 |
Antón, F; Aparici, M; Beleta, J; Calaf, E; Cárdenas, A; Cardús, A; Fonquerna, S; Gras, J; Huerta, JM; Miralpeix, M; Pagès, L; Prieto, J; Puig, C; Ryder, H; Vilella, D; Warrellow, G | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Bakker, RA; Leurs, R; Lim, HD; Ling, P; Thurmond, RL; van Rijn, RM | 1 |
Morphy, R; Rankovic, Z | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Jia, L; Sun, H | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Sen, S; Sinha, N | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Coussement, C; Ghys, L; Rihoux, JP; Van Neste, D | 1 |
Barkley, AS; Millard, LG; Shall, L; Thompson, DA | 1 |
O'Hanlon, JF; Ramaekers, JG; Uiterwijk, MM | 1 |
Arnaud, A; Cougnard, J; Czarlewski, W; Dry, J; Herman, D; Latil, G; Lisiecka, MZ; Pauli, G; Perrin-Fayolle, M; Vervloet, D | 1 |
Naclerio, RM | 2 |
Hill, S; Lever, LR; Marks, R; Rosenberg, R; Thompson, D | 1 |
Fletcher, MP; Ryhal, BT | 1 |
Soter, NA | 1 |
Gillardin, JM; Gommeren, W; Janssen, PA; Janssen, PF; Leysen, JE; Sanz, G; Schotte, A | 1 |
Humphreys, F; Hunter, JA | 1 |
Coulie, P; Ghys, L; Rihoux, JP | 1 |
McMillan, JL; Simons, FE; Simons, KJ | 1 |
Woodward, JK | 1 |
Kaiser, HB | 1 |
Simons, FE | 1 |
Herakleous, M; Kontou-Fili, K; Paleologos, G | 1 |
O'Hanlon, JF; Ramaekers, JG | 1 |
Tarchalska-Kryńska, B; Zawisza, E | 1 |
Arron, RJ; Bogdanovic, RP; Brandes, LJ; Fang, W; LaBella, FS; Queen, GM; Stein, DA; Tong, J; Warrington, RC; Zaborniak, CL | 1 |
Dowd, PM; Goldsmith, P | 1 |
Rihoux, JP; Van Neste, D | 1 |
Meltzer, EO; Weiler, JM; Widlitz, MD | 1 |
Cabanis, MJ; Caplain, H; Chaufour, S; Rosenzweig, P; Thebault, JJ; Ulliac, N | 1 |
Woosley, RL | 1 |
Bewley, AP; Church, MK; Malhotra, D; Perzanowska, M; Petersen, LJ; Rihoux, JP; Skinner, SP | 1 |
Aloui, R; Amsellem, C; Czarlewski, W; Gormand, F; Guibert, B; Hosni, R; Lagarde, M; Melac, M; Pacheco, Y; Perrin-Fayolle, M | 1 |
DeMora, F; Ferrer, L; García, G; Puigdemont, A | 1 |
Benabdesselam, O; Braun, JJ; Frossard, N; Glasser, N; Lacronique, J; Melac, M; Pauli, G | 1 |
Clark, S | 1 |
Edwards, IR; Lindquist, M | 1 |
Briscoe, MP; Clark, RH; Day, JH; Ellis, AK; Gervais, P | 1 |
Bousquet, J; Campbell, A; Chanal, I; Czarlewski, W; Michel, FB | 1 |
Canonica, GW; Ciprandi, G; Danzig, M; Passalacqua, G; Pronzato, C; Ricca, V | 1 |
Delgado, LF; Naspitz, CK; Pferferman, A; Solé, D | 1 |
Briscoe, M; Day, JH; Widlitz, MD | 1 |
Estes, KS; González, MA | 1 |
Annunziato, L; Castaldo, P; Genovese, A; Giorgio, G; January, CT; Marone, G; Pannaccione, A; Taglialatela, M; Zhou, Z | 1 |
Bennett, AR; Church, MK; Clough, GF | 1 |
Burtin, B; Donnelly, F; Rihoux, JP | 1 |
Fraser, TG; Maher, J; Pillay, N; Simons, FE; Simons, KJ | 1 |
Benabdesselam, O; Frossard, N; Glasser, N; Lacronique, J; Melac, M; Pauli, G | 1 |
Bousquet, J; Demoly, P; Harris, AG; Michel, FB; Persi, L; Tisserand, B | 1 |
Stone, BD | 1 |
de Abajo, FJ; Rodríguez, LA | 1 |
Mattila, MJ; Paakkari, I | 1 |
Del Rio-Navarro, B; Gazca-Aguilar, A; Sienra-Monge, JJ | 1 |
Danielson, L; DeVos, C; Grant, JA; Rihoux, JP | 1 |
Altintaş, L; Apaydýn, R; Bayramgürler, D; Bilen, N; Dökmeci, S; Sal, G; Utkan, T | 1 |
Collart, P; Nicolas, JM; Roba, J; Whomsley, R | 1 |
Dunn, N; Mann, RD; Pearce, GL; Shakir, S | 1 |
Abdelaziz, MM; Devalia, JL; Khair, OA | 1 |
Gates, D; Greiding, L; Heithoff, K; Ramon, F; Salmun, LM; Scharf, M | 1 |
Jean, CD; Triplett, JW | 1 |
Johnston, L; Simons, FE; Simons, KJ | 1 |
Benedetto, SR; Duncan, BS; Sloan, AS | 1 |
de Longueville, M | 1 |
Bouvy, ML; Egberts, TC | 1 |
Hindmarch, I; Kimber, S; Shamsi, Z | 1 |
Cummins, G; Lee, J; Okamoto, L | 1 |
Boutsiouki, P; Church, MK; Clough, GF | 1 |
Cummins, G; Leahy, M; Liao, E | 1 |
Annunziato, L; Castaldo, P; Fresi, A; Giorgio, G; Pannaccione, A; Rosati, B; Secondo, A; Taglialatela, M; Wanke, E | 1 |
Briscoe, M; Chapman, D; Day, JH; Kramer, B; Rafeiro, E | 1 |
DeVos, C; Grant, JA; Moulaert, B; Riethuisen, JM | 1 |
Hindmarch, I; Johnson, S; Kirkpatrick, T; Meadows, R; Shamsi, Z | 1 |
Wilson, AM | 1 |
Fridliand, DG; Gushchin, IS; Poroshina, IuA; Shul'zhenko, AE | 1 |
Burri, P; Karppinen, A; Kautiainen, H; Petman, L; Reunala, T | 1 |
Paakkari, I | 1 |
Spencer, HM | 1 |
Antonijoan, R; Barbanoj, M; Esbrí, R; Garcia, E; Gich, I; Gispert, J; Luria, X | 1 |
Bates, CE; Currie, GP; Lee, DK; Lipworth, BJ | 1 |
Gras, J; Llenas, J; Llupià, J | 1 |
Boyce, M; Carey, W; Luria, X; Warrington, S | 1 |
Scheinfeld, N | 1 |
Frossard, N; Melac, M; Pauli, G; Purohit, A | 2 |
Boutsiouki, P; Church, MK; Clough, GF; Denham, KJ | 1 |
Grzelewska-Rzymowska, I | 1 |
Fujii, Y; Harada, C; Hirai, T; Kamei, C; Tanaka, T | 1 |
Glass, D; Harper, A | 1 |
Briscoe, MP; Day, JH; Rafeiro, E; Ratz, JD | 1 |
Fujihara, S; Gardiner, M; Haggart, K; Lee, DK; Lipworth, BJ | 1 |
Magnan, A | 1 |
Berney, M; Deruaz, C; Leimgruber, A; Pradervand, E; Spertini, F | 1 |
Ciprandi, G; Cirillo, I; Tosca, MA; Vizzaccaro, A | 1 |
Horak, F; Stübner, P; Zieglmayer, R | 1 |
Fooanant, S; Roongapinun, S; Wajajamreon, S | 1 |
Baiardini, I; Canonica, GW; Compalati, E; Fumagalli, F; Guerra, L; Massacane, P; Pasquali, M | 1 |
Benedetti, MS; Diquet, B; Molimard, M | 1 |
Baena-Cagnani, R; Canonica, GW; Compalati, E; Guerra, L; Massacane, P; Passalacqua, G; Rogkakou, A; Zanella, C | 1 |
Currie, GP; Lee, DK | 1 |
Abelson, MB; Gupta, G; Ousler, GW; Wilcox, KA | 1 |
Riechelmann, H | 1 |
Fujieda, S; Hyo, S; Kawada, R; Kitazawa, S; Takenaka, H | 1 |
Ekins-Daukes, S; Helms, PJ; McLay, JS; Taylor, MW | 1 |
Conboy-Ellis, K | 1 |
Canonica, GW; Passalacqua, G | 1 |
Baltes, E; Benedetti, MS; Chatelain, P; Gillard, M | 1 |
Allen, M; Barberi, S; Ciprandi, G; Cirillo, I; Civardi, E; Marseglia, GL; Vizzaccaro, A | 1 |
Shedden, A | 1 |
Hansen, RA; Trygstad, TK; Wegner, SE | 1 |
Chang, WC; Cheng, KC; Chi, CS; Chu, JJ; Fu, LS; Hsu, JY | 1 |
Brunton, S; Spangler, DL | 1 |
Bachvarova, A; Bocsan, C; Church, MK; Dimitrov, V; Dumitrascu, D; Popov, TA | 1 |
Boshier, A; Cornelius, V; Harris, S; Layton, D; Shakir, SA; Wilton, L | 1 |
Camelo-Nunes, IC | 1 |
Ciebiada, M; DuBuske, LM; Górska-Ciebiada, M; Górski, P | 1 |
Blaiss, MS; Lehman, JM | 1 |
Aragane, Y; Ashenager, MS; Grgela, T; Kawada, A | 1 |
Kruszewski, J; Kłos, K; Sułek, K | 1 |
Kruszewski, J; Kruszewski, R; Kłos, K; Sułek, K | 1 |
Calmels, T; Leppaenen, J; Mach, UR; Sasse, BC; Stark, H | 1 |
Frossard, N; Pauli, G; Purohit, A; Strolin-Benedetti, M | 1 |
Chimona, TS; Helidonis, ES; Panayiotides, JG; Papadakis, CE; Velegrakis, GA | 1 |
Du, XH; Liu, ZH | 1 |
Devillier, P; Faisy, C; Roche, N | 1 |
Apostolou, C; Dotsikas, Y; Kousoulos, C; Loukas, YL | 1 |
Ciebiada, M; Ciebiada, MG; DuBuske, LM; Gorski, P; Kmiecik, T | 1 |
Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC | 1 |
Bachert, C | 1 |
Bagad, AS; Bahekar, PC; Chidrewar, GU; Mandhane, SN; Mehetre, SV; Pawar, CA; Rajamannar, T; Rao, CT; Shah, JH | 1 |
Moeller, ML; Nahata, MC; Phan, H | 1 |
Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M | 1 |
Chu, CY; Hong, JB; Hu, FC; Lee, HC | 1 |
Bobadilla-González, P; Cámara-Hijón, C; García-Menaya, JM; Pérez-Rangel, I; Sánchez-Vega, S | 1 |
Chu, CY; Hong, JB; Lee, HC | 1 |
Köberlein, J; König, V; Mösges, R | 1 |
Crowe, A; Wright, C | 1 |
Carter, NJ | 1 |
Church, MK; Maurer, M | 1 |
Bayramgürler, D; Bilen, N; Bulca, S; Kıran, R; Odyakmaz Demirsoy, E; Sikar Aktürk, A; Yavuz, M | 1 |
Kamenica, E; Malani, A; Naclerio, R | 1 |
Barylski, M; Ciebiada, M; Ciebiada, MG | 1 |
Arslanoglu, S; Inan, S; Kirtay, S; Onal, K; Ozkul, Y; Ozkut, M; Songu, M | 1 |
Plichta, D; Spiewak, R | 1 |
Başak, PY; Buyukbayram, HI; Erturan, I; Kazanoglu, OO; Vural, H | 1 |
Bennett, C; Carter, B; Cohen, SN; Sharma, M | 1 |
Enk, CD; Levi, A | 1 |
Bosma, R; Leurs, R; Moritani, R; Vischer, HF | 1 |
Berger, WE; Franklin, KB; LaForce, CF; Nayak, AS; Patel, MK; Urdaneta, ER; Wu, MM | 1 |
Biagi, C; Calamelli, E; Cipriani, F; Donati, M; Melis, M; Monaco, L; Motola, D; Ricci, G; Vaccheri, A | 1 |
Kanaoka, T; Matsuoka, K; Shaker, M | 1 |
Berstecher, B; Sahin, T; Schaefer, M | 1 |
Apfelbacher, CJ; Böhmer, MM; Carter, B; Jupiter, A; Matterne, U; Weisshaar, E | 1 |
Enk, CD; Hodak, E; Lapidoth, M; Levi, A; Mazor, S; Snast, I; Uvaidov, V | 1 |
Hanazawa, T; Iinuma, T; Kawasaki, Y; Kurita, J; Okamoto, Y; Sakurai, D; Sakurai, T; Yoneda, R; Yonekura, S | 1 |
Akram, S; Ali, SN; Iqbal, S; Naz, N; Qayoom, A | 1 |
Guan, W; Hu, N; Lin, W; Liu, A; Ping, S; Ren, Y; Zheng, S | 1 |
He, M; Qin, W; Qin, Z; Zhao, C | 1 |
34 review(s) available for cetirizine and loratadine
Article | Year |
---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The second-generation antihistamines. What makes them different?
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Blood-Brain Barrier; Brain; Cetirizine; Cyproheptadine; Education, Medical, Continuing; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; Loratadine; Terfenadine | 1991 |
H1-receptor antagonist treatment of seasonal allergic rhinitis.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Chlorpheniramine; Clemastine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Ketotifen; Loratadine; Rhinitis, Allergic, Seasonal; Terfenadine | 1990 |
Recent advances in H1-receptor antagonist treatment.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Receptors, Histamine H1; Rhinitis, Allergic, Perennial; Terfenadine; Urticaria | 1990 |
Three new non-sedative antihistamines: worth keeping an eye open for.
Topics: Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Rhinitis, Allergic, Seasonal; Triprolidine; Urticaria | 1990 |
The new H1 antihistamines. Treatment of urticaria and other clinical problems.
Topics: Astemizole; Cetirizine; Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Loratadine; Terfenadine; Triprolidine; Urticaria | 1993 |
Cardiac actions of antihistamines.
Topics: Animals; Astemizole; Cetirizine; Diphenhydramine; Drug Interactions; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Terfenadine; Torsades de Pointes | 1996 |
Pharmacokinetic overview of oral second-generation H1 antihistamines.
Topics: Astemizole; Blood-Brain Barrier; Cetirizine; Histamine H1 Antagonists; Humans; Loratadine; Structure-Activity Relationship; Terfenadine; Therapeutic Equivalency; Torsades de Pointes | 1998 |
Variations among non-sedating antihistamines: are there real differences?
Topics: Astemizole; Benzimidazoles; Butyrophenones; Central Nervous System; Cetirizine; Drug Interactions; Heart; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Loratadine; Piperidines; Potassium Channel Blockers; Terfenadine; Triprolidine | 1999 |
What are the candidate groups for pharmacotherapeutic intervention to prevent asthma?
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child; Clinical Trials as Topic; Cromolyn Sodium; Dermatitis, Atopic; Genetic Predisposition to Disease; Humans; Hypersensitivity; Loratadine; Risk Factors | 2000 |
Are antihistamines useful in managing asthma?
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchospirometry; Cetirizine; Cyclopropanes; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Loratadine; Mannitol; Quinolines; Rhinitis; Sulfides; Terfenadine | 2002 |
Cardiotoxicity of new antihistamines and cisapride.
Topics: Arrhythmias, Cardiac; Astemizole; Benzimidazoles; Butyrophenones; Cetirizine; Cisapride; Heart Diseases; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Serotonin Receptor Agonists; Terfenadine; Triprolidine | 2002 |
The new antihistamines--desloratadine and levocetirizine: a review.
Topics: Acetates; Animals; Area Under Curve; Cetirizine; Half-Life; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Piperazines; Randomized Controlled Trials as Topic | 2002 |
[Clinical aspects of anti-inflammatory action of antihistamines].
Topics: Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Piperazines; Terfenadine | 2003 |
Antihistamines: do they work? Further well-controlled trials involving larger samples are needed.
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Piperazines; Quality of Life | 2004 |
Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
Topics: Absorption; Animals; Area Under Curve; Benzimidazoles; Biological Availability; Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Metabolic Clearance Rate; Piperazines; Terfenadine; Tissue Distribution | 2004 |
[Oral second generation antihistamines in allergic rhinitis].
Topics: Administration, Oral; Adult; Anti-Allergic Agents; Cetirizine; Child; Conjunctivitis, Allergic; Controlled Clinical Trials as Topic; Female; Histamine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Loratadine; Male; Nasal Mucosa; Pregnancy; Receptors, Histamine; Receptors, Histamine H1; Receptors, Histamine H2; Rhinitis, Allergic, Seasonal; Time Factors | 2005 |
Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.
Topics: Adolescent; Adult; Cetirizine; Child; Child, Preschool; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Nurse Practitioners; Rhinitis, Allergic, Seasonal; Terfenadine; Treatment Outcome | 2005 |
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
Topics: Cetirizine; Histamine Antagonists; Humans; Loratadine; Nose; Piperazines; Quality of Life; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Skin; Urticaria | 2005 |
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
Topics: Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperazines; Retrospective Studies; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2006 |
Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
Topics: Central Nervous System; Cetirizine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Quality of Life; Rhinitis, Allergic, Seasonal; Terfenadine | 2006 |
New antihistamines: a critical view.
Topics: Anti-Allergic Agents; Blood-Brain Barrier; Central Nervous System Diseases; Cetirizine; Child; Cyproheptadine; Heart Diseases; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Mast Cells; Piperazines; Receptors, Histamine H1; Terfenadine | 2006 |
Selecting the optimal oral antihistamine for patients with allergic rhinitis.
Topics: Administration, Oral; Cardiovascular System; Central Nervous System; Cetirizine; Drug Interactions; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Long QT Syndrome; Loratadine; Piperazines; Practice Guidelines as Topic; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Terfenadine; Treatment Outcome | 2006 |
Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Topics: Cetirizine; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Terfenadine; Urticaria | 2008 |
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cetirizine; Child; Clinical Trials as Topic; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nasal Obstruction; Rhinitis, Allergic, Seasonal; Terfenadine; Treatment Outcome; Young Adult | 2009 |
Cetirizine and loratadine: minimal risk of QT prolongation.
Topics: Anti-Allergic Agents; Cetirizine; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Long QT Syndrome; Loratadine; Risk | 2010 |
The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis.
Topics: Anti-Allergic Agents; Cetirizine; Humans; Loratadine; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2011 |
Bilastine: in allergic rhinitis and urticaria.
Topics: Area Under Curve; Benzimidazoles; Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Urticaria | 2012 |
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
Topics: Anti-Allergic Agents; Cetirizine; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Predictive Value of Tests; Skin Tests; Terfenadine; Urticaria | 2012 |
[Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs].
Topics: Administration, Oral; Administration, Topical; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Glucocorticoids; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Poland; Practice Guidelines as Topic; Terfenadine; Treatment Outcome; Urticaria | 2013 |
H1-antihistamines for chronic spontaneous urticaria.
Topics: Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Randomized Controlled Trials as Topic; Urticaria | 2014 |
Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Topics: Administration, Oral; Administration, Topical; Adult; Cetirizine; Chemotherapy, Adjuvant; Child; Eczema; Histamine H1 Antagonists; Humans; Loratadine; Outcome Assessment, Health Care; Pruritus; Randomized Controlled Trials as Topic; Terfenadine | 2019 |
Acupuncture for allergic rhinitis: a systematic review and meta-analysis.
Topics: Acupuncture Therapy; Adolescent; Adult; Cetirizine; Child; Humans; Loratadine; Quality of Life; Rhinitis, Allergic; Surveys and Questionnaires | 2022 |
71 trial(s) available for cetirizine and loratadine
Article | Year |
---|---|
Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P.
Topics: Adult; Blood Flow Velocity; Cetirizine; Female; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Loratadine; Male; Middle Aged; Skin; Skin Tests; Substance P | 1992 |
Comparative inhibition profiles of three non-sedating antihistamines assessed by an extended Lewis model.
Topics: Adult; Analysis of Variance; Cetirizine; Cyproheptadine; Female; Histamine Antagonists; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Immediate; Injections, Intradermal; Loratadine; Male; Models, Biological; Single-Blind Method; Skin; Skin Tests; Terfenadine | 1992 |
Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving.
Topics: Adult; Automobile Driving; Cetirizine; Cyproheptadine; Double-Blind Method; Electroencephalography; Ethanol; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Male; Psychological Tests; Psychometrics; Psychomotor Performance | 1992 |
[Clinical effectiveness and tolerance of loratadine versus cetirizine in the treatment of seasonal allergic rhinitis].
Topics: Adult; Cetirizine; Double-Blind Method; Drug Tolerance; Female; Humans; Loratadine; Male; Rhinitis, Allergic, Seasonal | 1992 |
Inhibition of mediator release during the early reaction to antigen.
Topics: Albumins; Antigens; Cetirizine; Esterases; Histamine; Humans; Kinins; Loratadine; Nasal Mucosa; Nasal Provocation Tests; Terfenadine; Tosylarginine Methyl Ester | 1992 |
Effects of cetirizine, loratadine and terfenadine on histamine weal and flare reactions.
Topics: Administration, Oral; Adult; Cetirizine; Cyproheptadine; Double-Blind Method; Erythema; Female; Histamine; Histamine Antagonists; Humans; Hydroxyzine; Loratadine; Male; Middle Aged; Random Allocation; Skin; Terfenadine | 1992 |
The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.
Topics: Adult; Animals; Antigens; Astemizole; Cetirizine; Codeine; Cyproheptadine; Dermatitis, Contact; Dust; Female; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Male; Middle Aged; Mites; Skin; Time Factors | 1991 |
Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine.
Topics: Adult; Cetirizine; Cyproheptadine; Double-Blind Method; Drug Hypersensitivity; Female; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Immediate; Hypnotics and Sedatives; Loratadine; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic | 1990 |
A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
Topics: Adult; Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Chlorpheniramine; Cyproheptadine; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Male; Placebos; Skin Tests; Terfenadine; Time Factors; Urticaria | 1990 |
Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl.
Topics: Adult; Cetirizine; Cyproheptadine; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Middle Aged; Random Allocation; Skin | 1989 |
Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
Topics: Automobile Driving; Benzimidazoles; Butyrophenones; Cetirizine; Clemastine; Diphenhydramine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Humans; Loratadine; Netherlands; Piperidines; Psychomotor Performance; Terfenadine; Triprolidine | 1995 |
Effects of antihistamines on inflammatory mediators.
Topics: Cetirizine; Chymases; Histamine H1 Antagonists; Histamine H2 Antagonists; Histamine Release; Humans; Loratadine; Nasal Provocation Tests; Prostaglandin D2; Serine Endopeptidases; Terfenadine; Tryptases | 1993 |
[Test for efficacy of cetirizine and loratadine as a treatment for seasonal allergic rhinitis in a 6 week cross-over comparative study].
Topics: Adolescent; Adult; Cetirizine; Conjunctivitis; Cross-Over Studies; Female; Humans; Loratadine; Male; Middle Aged; Rhinitis, Allergic, Seasonal | 1994 |
Dynamics of the skin blood flow response to histamine. Comparison of the effects of cetirizine and loratadine on the skin response to a histamine dry prick test monitored with laser-Doppler flowmetry.
Topics: Adult; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Intradermal Tests; Laser-Doppler Flowmetry; Loratadine; Male; Regional Blood Flow; Skin | 1993 |
Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis.
Topics: Adolescent; Adult; Cetirizine; Child; Double-Blind Method; Female; Humans; Loratadine; Male; Middle Aged; Placebos; Pollen; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Time Factors | 1996 |
Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
Topics: Adult; Benzimidazoles; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Loratadine; Male; Terfenadine | 1995 |
The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.
Topics: Adult; Cetirizine; Codeine; Double-Blind Method; Histamine H1 Antagonists; Histamine Release; Humans; Loratadine; Microdialysis; Skin | 1996 |
Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis.
Topics: Adult; Airway Resistance; Animals; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Infant, Newborn; Loratadine; Male; Nasal Mucosa; Nasal Provocation Tests; Rhinitis, Allergic, Seasonal; Time Factors | 1997 |
Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Astemizole; Cetirizine; Double-Blind Method; Environmental Exposure; Female; Humans; Loratadine; Male; Middle Aged; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sneezing; Terfenadine; Treatment Outcome | 1997 |
Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis.
Topics: Adult; Albumins; Cetirizine; Double-Blind Method; Epithelial Cells; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Loratadine; Nasal Lavage Fluid; Nasal Mucosa; Rhinitis, Allergic, Seasonal; Seasons | 1997 |
Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Topics: Adolescent; Adult; Blood Proteins; Cetirizine; Eosinophil Granule Proteins; Eosinophil Peroxidase; Eosinophils; Epithelial Cells; Female; Histamine; Histamine H1 Antagonists; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Leukocyte Count; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Neutrophils; Peroxidase; Peroxidases; Rhinitis, Allergic, Seasonal; Ribonucleases; Seasons | 1997 |
Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Topics: Anti-Allergic Agents; Anti-Bacterial Agents; Astemizole; Cetirizine; Child; Child, Preschool; Drug Interactions; Electrocardiography; Erythromycin; Female; Heart; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Loratadine; Male; Terfenadine | 1998 |
Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allergens; Anti-Allergic Agents; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Poaceae; Pollen; Rhinitis, Allergic, Seasonal | 1998 |
Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Topics: Adult; Bradykinin; Cetirizine; Dermatitis, Allergic Contact; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Laser-Doppler Flowmetry; Loratadine; Male; Microcirculation; Microdialysis; Middle Aged; Skin | 1998 |
Central nervous system effects of H1-receptor antagonists in the elderly.
Topics: Aged; Blood Glucose; Brain; Cetirizine; Chlorpheniramine; Cognition Disorders; Cross-Over Studies; Diphenhydramine; Double-Blind Method; Event-Related Potentials, P300; Female; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Loratadine; Male; Memory Disorders; Psychomotor Performance; Safety; Skin Tests; Sleep Stages | 1999 |
Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis.
Topics: Adult; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Nasal Mucosa; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 1998 |
Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Topics: Adult; Allergens; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Nasal Provocation Tests; Poaceae; Rhinitis, Allergic, Seasonal; Skin Tests | 1999 |
Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.
Topics: Cetirizine; Child, Preschool; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists; Humans; Longitudinal Studies; Loratadine; Male; Patient Dropouts; Prospective Studies; Rhinitis, Allergic, Perennial; Skin Tests; Time Factors; Treatment Outcome | 1999 |
A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Topics: Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Dibenzazepines; Double-Blind Method; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Imidazoles; Loratadine; Male; Piperidines; Skin Tests; Terfenadine; Urticaria | 1999 |
Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Topics: Adult; Cetirizine; Cross-Over Studies; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Single-Blind Method; Triprolidine; Urticaria | 1999 |
Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Disorders of Excessive Somnolence; Double-Blind Method; Efficiency; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Motivation; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Work | 2000 |
Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
Topics: Anti-Allergic Agents; Cetirizine; Child; Cross-Over Studies; Double-Blind Method; Histamine H1 Antagonists; Humans; Loratadine; Prospective Studies; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2000 |
Consequences of a change in reimbursement status on prescription patterns.
Topics: Adult; Cetirizine; Drug Prescriptions; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Netherlands; Nonprescription Drugs; Reimbursement Mechanisms | 2000 |
An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers.
Topics: Adult; Cetirizine; Cognition; Cross-Over Studies; Double-Blind Method; Female; Flicker Fusion; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Promethazine; Psychomotor Performance; Reaction Time | 2001 |
Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin.
Topics: Anti-Allergic Agents; Cetirizine; Double-Blind Method; Histamine; Humans; Hypersensitivity, Immediate; Loratadine; Skin Tests; Urticaria | 2001 |
Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
Topics: Adolescent; Adult; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Pollen; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Treatment Outcome | 2001 |
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Topics: Adult; Benzimidazoles; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Piperidines; Terfenadine; Treatment Outcome; Urticaria | 2002 |
The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
Topics: Adult; Analysis of Variance; Area Under Curve; Cetirizine; Cognition; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Promethazine; Psychometrics; Psychomotor Performance; Reaction Time; Skin Tests | 2001 |
Comparison of cetirizine, ebastine and loratadine in the treatment of immediate mosquito-bite allergy.
Topics: Adult; Animals; Butyrophenones; Cetirizine; Conscious Sedation; Cross-Over Studies; Culicidae; Double-Blind Method; Finland; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Insect Bites and Stings; Loratadine; Middle Aged; Piperidines; Pruritus; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Topics: Adolescent; Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Kinetics; Loratadine; Male; Middle Aged; Piperidines; Skin Tests | 2002 |
Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma.
Topics: Acetates; Adenosine Monophosphate; Adult; Aged; Asthma; Bronchial Provocation Tests; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Piperazines; Respiratory Hypersensitivity; Terfenadine | 2003 |
Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Topics: Adolescent; Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Injections, Intradermal; Loratadine; Male; Piperidines; Skin Tests; Terfenadine | 2002 |
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
Topics: Adolescent; Adult; Cetirizine; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Skin; Urticaria | 2003 |
Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Double-Blind Method; Erythema; Histamine; Histamine H1 Antagonists; Humans; Injections, Intradermal; Laser-Doppler Flowmetry; Loratadine; Male; Pruritus; Regional Blood Flow; Skin | 2003 |
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).
Topics: Adolescent; Adult; Cetirizine; Cohort Studies; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Piperazines; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Treatment Outcome | 2004 |
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Nasal Provocation Tests; Piperazines; Rhinitis, Allergic, Perennial; Terfenadine; Treatment Outcome | 2004 |
Levocetirizine better protects than desloratadine in a nasal provocation with allergen.
Topics: Adult; Albumins; Allergens; Biomarkers; Cetirizine; Cross-Over Studies; Differential Threshold; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Male; Nasal Lavage Fluid; Nasal Provocation Tests; Piperazines; Poaceae; Pollen; Treatment Outcome | 2004 |
Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
Topics: Adult; Cetirizine; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists; Humans; Interleukin-4; Interleukin-8; Leukocyte Count; Loratadine; Male; Nasal Lavage Fluid; Nasal Obstruction; Pilot Projects; Piperazines; Rhinitis, Allergic, Seasonal; Statistics, Nonparametric | 2004 |
A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Topics: Cetirizine; Cross-Over Studies; Double-Blind Method; Environmental Exposure; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Piperazines; Placebos; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Seasons; Treatment Outcome | 2004 |
Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Topics: Adolescent; Adult; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Terfenadine; Urticaria | 2004 |
Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Topics: Adolescent; Adult; Anti-Allergic Agents; Area Under Curve; Cetirizine; Cross-Over Studies; Female; Histamine; Humans; Loratadine; Male; Middle Aged; Skin Tests; Time Factors; Urticaria | 2004 |
Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
Topics: Adolescent; Adult; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nose; Piperazines; Rhinitis; Skin; Skin Tests; Treatment Outcome | 2004 |
An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride.
Topics: Adult; Aged; Cetirizine; Double-Blind Method; Dry Eye Syndromes; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged | 2004 |
The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen.
Topics: Adult; Cetirizine; Cryptomeria; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Japan; Loratadine; Male; Middle Aged; Pollen; Quality of Life; Rhinitis, Allergic, Seasonal; Sneezing; Surveys and Questionnaires; Terfenadine | 2005 |
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Topics: Adolescent; Adult; Cetirizine; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Interleukin-4; Leukocyte Count; Loratadine; Male; Nasal Lavage Fluid; Nasal Mucosa; Nasal Obstruction; Pilot Projects; Piperazines; Rhinitis, Allergic, Perennial; Rhinomanometry | 2005 |
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Topics: Adult; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Loratadine; Male; Middle Aged; Piperazines; Skin; Skin Tests; Urticaria | 2006 |
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
Topics: Adult; Cetirizine; Cohort Studies; Conscious Sedation; Drug Monitoring; England; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Piperazines; Rhinitis; Sleep Stages | 2006 |
Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Cetirizine; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Eosinophil Cationic Protein; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nasal Lavage Fluid; Piperazines; Quinolines; Rhinitis, Allergic, Perennial; Rhinometry, Acoustic; Sulfides; Treatment Outcome | 2006 |
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Laser-Doppler Flowmetry; Loratadine; Male; Piperazines; Placebos; Skin; Skin Tests; Terfenadine; Treatment Outcome; Urticaria | 2006 |
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Drug Administration Schedule; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Laser-Doppler Flowmetry; Loratadine; Male; Piperazines; Regional Blood Flow; Skin; Skin Tests; Terfenadine; Treatment Outcome; Urticaria | 2006 |
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
Topics: Adolescent; Adult; Allergens; Cetirizine; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Piperazines; Prospective Studies; Urticaria | 2008 |
Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Topics: Acetates; Adolescent; Adult; Aged; Cetirizine; Chronic Disease; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Interactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quality of Life; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sulfides; Treatment Outcome | 2008 |
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pruritus; Quality of Life; Severity of Illness Index; Urticaria | 2009 |
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Topics: Adult; Aged; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Quality of Life; Urticaria; Young Adult | 2010 |
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pilot Projects; Sleep Stages; Urticaria | 2010 |
Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Time Factors; Urticaria; Young Adult | 2013 |
Advertisements impact the physiological efficacy of a branded drug.
Topics: Adult; Advertising; Cetirizine; Female; Follow-Up Studies; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity; Loratadine; Male; Television; Time Factors; Treatment Outcome | 2013 |
Wheal and flare reactions in skin prick tests of patients treated with montelukast alone or in combination with antihistamines.
Topics: Acetates; Adolescent; Adult; Aged; Antigens; Antigens, Dermatophagoides; Cetirizine; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Female; Histamine Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Prospective Studies; Quinolines; Rhinitis, Allergic, Perennial; Skin; Skin Tests; Sulfides; Young Adult | 2014 |
Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.
Topics: Anti-Allergic Agents; Cetirizine; Child; Female; Headache; Humans; Loratadine; Male; Pharyngitis; Rhinitis, Allergic, Seasonal; Seasons; Severity of Illness Index | 2017 |
Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Cetirizine; Female; Humans; Loratadine; Male; Placebo Effect; Placebos; Quality of Life; Rhinitis, Allergic; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2018 |
Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
Topics: Adult; Cedrus; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Placebos; Pollen; Rhinitis, Allergic, Seasonal | 2019 |
68 other study(ies) available for cetirizine and loratadine
Article | Year |
---|---|
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
Topics: Alkanes; Animals; Biological Transport; Blood Proteins; Brain; Cetirizine; Histamine H1 Antagonists; Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydroxyzine; Isomerism; Models, Molecular; Molecular Conformation; Octanols; Rats; Water | 1998 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.
Topics: Animals; Cetirizine; Guinea Pigs; Histamine H1 Antagonists; Lipoxygenase Inhibitors; Loratadine; Models, Animal; Molecular Structure; Rats; Structure-Activity Relationship | 2004 |
Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Electrocardiography; Guinea Pigs; Half-Life; Histamine H1 Antagonists; Humans; In Vitro Techniques; Indoles; Male; Mice; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Histamine H1; Receptors, Serotonin; Skin; Structure-Activity Relationship | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
Topics: Cell Line; Histamine Agonists; Humans; Imidazoles; Indoles; Isothiuronium; Ligands; Methylhistamines; Piperazines; Radioligand Assay; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3; Receptors, Histamine H4 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Topics: Angioedema; Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Terfenadine; Urticaria | 1991 |
[Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cerebellum; Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Hydroxyzine; Kinetics; Loratadine; Lung; Organ Specificity; Protein Binding; Receptors, Histamine H1; Terfenadine | 1991 |
Pharmacology of antihistamines.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Terfenadine; Time Factors | 1990 |
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates.
Topics: Animals; Astemizole; Carcinogens; Cetirizine; Doxylamine; Female; Histamine H1 Antagonists; Hydroxyzine; Loratadine; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley | 1994 |
Antihistamines and production of granulocyte-macrophage colony-stimulating factor and interleukin-8 by human bronchial epithelial cells in vitro: evaluation of the effects of loratadine and cetirizine.
Topics: Adult; Aged; Bronchi; Cells, Cultured; Cetirizine; Enzyme-Linked Immunosorbent Assay; Epithelium; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine H1 Antagonists; Humans; Interleukin-8; Loratadine; Male; Middle Aged; Tumor Necrosis Factor-alpha | 1996 |
Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
Topics: Animals; Calcimycin; Cell Survival; Cetirizine; Concanavalin A; Dermatitis, Atopic; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Ketotifen; Loratadine; Mast Cells; Skin; Substance P; Terfenadine | 1997 |
Dangers of non-sedating antihistamines.
Topics: Arrhythmias, Cardiac; Astemizole; Cetirizine; Heart Diseases; Histamine H1 Antagonists; Humans; Legislation, Drug; Liver Diseases; Loratadine; Terfenadine; United Kingdom | 1997 |
Risks of non-sedating antihistamines.
Topics: Adverse Drug Reaction Reporting Systems; Astemizole; Cetirizine; Histamine H1 Antagonists; Humans; Loratadine; Terfenadine; Triprolidine | 1997 |
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
Topics: Animals; Astemizole; Cation Transport Proteins; Cetirizine; DNA-Binding Proteins; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Heart; Histamine H1 Antagonists; Humans; Loratadine; Oocytes; Potassium Channels; Potassium Channels, Voltage-Gated; Receptors, Histamine H1; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Transfection; Tumor Cells, Cultured; Xenopus laevis | 1998 |
The clinical efficacy of H1 antagonists in urticaria and rhinitis.
Topics: Anti-Allergic Agents; Cetirizine; Histamine H1 Antagonists; Humans; Loratadine; Mathematical Computing; Rhinitis, Allergic, Seasonal; Terfenadine; Urticaria | 1998 |
Same drug, different outcomes in the environmental exposure unit.
Topics: Anti-Allergic Agents; Cetirizine; Controlled Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Loratadine; Reproducibility of Results; Rhinitis, Allergic, Seasonal | 1999 |
Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Astemizole; Case-Control Studies; Cetirizine; Child; Child, Preschool; Cohort Studies; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Histamine H1 Antagonists; Humans; Infant; Infant, Newborn; Information Systems; Loratadine; Male; Middle Aged; Risk Factors; Tachycardia, Ventricular; Terfenadine; Triprolidine | 1999 |
In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines.
Topics: Astemizole; Benzimidazoles; Cetirizine; Cytochrome P-450 Enzyme Inhibitors; Dimethyl Sulfoxide; Enzyme Inhibitors; Glucuronosyltransferase; Histamine H1 Antagonists; Humans; Isoenzymes; Kinetics; Loratadine; Microsomes, Liver; Terfenadine | 1999 |
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Cetirizine; Child; Child, Preschool; Consciousness Disorders; Female; Histamine H1 Antagonists; Humans; Infant; Infant, Newborn; Loratadine; Male; Middle Aged; Product Surveillance, Postmarketing; Sleep Stages; Terfenadine; Triprolidine | 2000 |
The potential of active metabolites of antihistamines in the management of allergic disease.
Topics: Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Cetirizine; Chymases; Eosinophils; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity; Intercellular Adhesion Molecule-1; Interleukin-3; Interleukin-8; Loratadine; Mast Cells; Piperidines; Potassium Channel Blockers; Potassium Channels; Prostaglandin D2; Pyridines; Recombinant Fusion Proteins; Recombinant Proteins; Serine Endopeptidases; Terfenadine; Time Factors; Tryptases | 2000 |
Investigating patient experiences after a formulary change.
Topics: Anti-Allergic Agents; Cetirizine; Humans; Loratadine; Patient Satisfaction | 2000 |
Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
Topics: Analysis of Variance; Astemizole; Cetirizine; Cost Savings; Drug Costs; Drug Utilization; Health Maintenance Organizations; Histamine H1 Antagonists; Humans; Loratadine; Marketing of Health Services; Practice Patterns, Physicians'; Retrospective Studies; Terfenadine; United States | 2000 |
Newer antihistamines.
Topics: Administration, Oral; Anti-Allergic Agents; Cetirizine; Chlorpheniramine; Conscious Sedation; Diphenhydramine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Humans; Hypersensitivity; Loratadine; Psychomotor Performance; Rhinitis, Allergic, Seasonal; Somnambulism; Terfenadine | 2001 |
A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Databases as Topic; Drug Utilization Review; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Retrospective Studies; Rhinitis, Allergic, Perennial; Terfenadine; United States | 2001 |
The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cetirizine; Child; Cohort Studies; Drug Costs; Economics, Pharmaceutical; Female; Health Care Costs; Histamine H1 Antagonists; Humans; Loratadine; Male; Managed Care Programs; Middle Aged; Retrospective Studies; Rhinitis, Allergic, Perennial; Terfenadine; United States | 2001 |
Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Topics: Astemizole; Calcium; Calcium Channel Blockers; Calcium Channels; Cation Transport Proteins; Cetirizine; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Neuroblastoma; Norepinephrine; Potassium Channels; Potassium Channels, Voltage-Gated; Receptors, Histamine H1; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Tritium; Tumor Cells, Cultured | 2001 |
[Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Cetirizine; Clemastine; Female; Histamine H1 Antagonists; Humans; Hypersensitivity; Loratadine; Male; Piperidines; Pollen; Terfenadine | 2002 |
The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health.
Topics: Anti-Allergic Agents; Cetirizine; Drug Approval; Drug Costs; Drug Labeling; Drug Prescriptions; Gatekeeping; Humans; Legislation, Drug; Loratadine; Nonprescription Drugs; Public Health Practice; Terfenadine; United States; United States Food and Drug Administration | 2002 |
Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Topics: Aerosols; Airway Resistance; Algorithms; Animals; Anti-Allergic Agents; Bronchial Spasm; Butyrophenones; Cetirizine; Guinea Pigs; Histamine; Histamine H1 Antagonists; Leukotriene C4; Loratadine; Male; Ovalbumin; Piperidines | 2003 |
[Antihistaminics. Side effects also after raising dosage at the placebo level].
Topics: Anti-Allergic Agents; Benzimidazoles; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Meta-Analysis as Topic; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2003 |
[In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
Topics: Anti-Allergic Agents; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Multicenter Studies as Topic; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Time Factors | 2003 |
Epileptogenic activity induced by histamine H(1) antagonists in amygdala-kindled rats.
Topics: Amygdala; Animals; Cetirizine; Diphenhydramine; Electroencephalography; Epilepsy; Histamine H1 Antagonists; Injections, Intraperitoneal; Ketotifen; Kindling, Neurologic; Loratadine; Male; Pyrilamine; Rats; Rats, Wistar | 2003 |
Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
Topics: Anti-Allergic Agents; Cetirizine; Choice Behavior; Data Collection; Humans; Loratadine; Managed Care Programs; Nonprescription Drugs; Patient Satisfaction; Terfenadine; United States | 2004 |
[Respiratory allergies in the child and the adult].
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Allergens; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchial Hyperreactivity; Bronchodilator Agents; Cetirizine; Child; Diagnosis, Differential; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunotherapy; Loratadine; Phthalazines; Respiratory Hypersensitivity; Respiratory Therapy; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Skin Tests; Time Factors | 2004 |
Modern histamine H1-receptor antagonists in the unified airway.
Topics: Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Nasal Obstruction; Nasal Provocation Tests; Piperazines; Rhinitis, Allergic, Perennial | 2004 |
Off-label prescribing to children: attitudes and experience of general practitioners.
Topics: Albuterol; Anti-Allergic Agents; Anti-Bacterial Agents; Attitude of Health Personnel; Bronchodilator Agents; Cetirizine; Child; Child, Preschool; Drug Administration Schedule; Drug Information Services; Drug Labeling; Drug Prescriptions; Erythromycin; Family Practice; Health Knowledge, Attitudes, Practice; Humans; Infant; Loratadine; Penicillin V; Prospective Studies; Scotland | 2005 |
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
Topics: Animals; Cetirizine; CHO Cells; Cricetinae; Cricetulus; Histamine H1 Antagonists; Humans; Loratadine; Piperazines; Predictive Value of Tests; Receptors, Histamine H1; Recombination, Genetic; Terfenadine; Urticaria | 2005 |
Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability.
Topics: Cetirizine; Drug Utilization Review; Histamine H1 Antagonists, Non-Sedating; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Loratadine; Medicaid; Nonprescription Drugs; North Carolina; Retrospective Studies | 2006 |
Influence of cetirizine and loratadine on granulocyte-macrophage colony-stimulating factor and interleukin-8 release in A549 human airway epithelial cells stimulated with interleukin-1beta.
Topics: Cells, Cultured; Cetirizine; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-1; Interleukin-8; Loratadine; Lung | 2006 |
Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines.
Topics: Cells, Cultured; Cetirizine; Dibenzoxepins; Histamine H1 Antagonists, Non-Sedating; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukin-5; Loratadine; Olopatadine Hydrochloride; RNA, Messenger; T-Lymphocytes; Terfenadine | 2007 |
Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Topics: Amines; Animals; Binding, Competitive; Cell Line; Cetirizine; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Drug Design; Drug Evaluation, Preclinical; Histamine H1 Antagonists; Humans; Ketotifen; Ligands; Loratadine; Mianserin; Molecular Structure; Piperidines; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2007 |
Antihistamine effects on experimental middle ear inflammatory model.
Topics: Animals; Cetirizine; Disease Models, Animal; Ear, Middle; Female; Histamine H1 Antagonists, Non-Sedating; Loratadine; Male; Mucous Membrane; Otitis Media with Effusion; Rabbits | 2008 |
Quality of life in patients with facial steroid dermatitis before and after treatment.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Cetirizine; Dermatitis, Contact; Doxycycline; Drug Therapy, Combination; Face; Female; Humans; Indomethacin; Loratadine; Male; Middle Aged; Quality of Life; Severity of Illness Index | 2008 |
Comparison of hydrophilic interaction and reversed-phase liquid chromatography coupled with tandem mass spectrometric detection for the determination of three pharmaceuticals in human plasma.
Topics: Cetirizine; Chromatography, Liquid; Donepezil; Humans; Indans; Loratadine; Piperidines; Reproducibility of Results; Tandem Mass Spectrometry | 2008 |
Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
Topics: Acetates; Alcohols; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ataxia; Cetirizine; Drug Interactions; Female; Guinea Pigs; Histamine H1 Antagonists, Non-Sedating; Hydroxyzine; Hypersensitivity; Immunoglobulin G; Interleukin-4; Leukocytes; Loratadine; Male; Mice; Mice, Inbred BALB C; Nasal Lavage Fluid; Nasal Mucosa; Pentobarbital; Piperazines; Sneezing; Terfenadine | 2010 |
Best drugs for what ails you: the brands to buy--and those to skip.
Topics: Acetaminophen; Anesthetics, Local; Cetirizine; Chlorpheniramine; Common Cold; Cough; Dextromethorphan; Diphenhydramine; Drug Costs; Drug Therapy; Emergencies; Expectorants; First Aid; Glycerol; Guaifenesin; Histamine Antagonists; Honey; Humans; Hypersensitivity; Ibuprofen; Influenza Vaccines; Influenza, Human; Loratadine; Nonprescription Drugs; Oxymetazoline; Pharyngitis; Propiophenones; Pseudoephedrine; Rhinitis; Sodium Chloride | 2009 |
Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.
Topics: Acetates; Administration, Oral; Adult; Anti-Allergic Agents; Anti-Asthmatic Agents; Astemizole; Cetirizine; Child; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Ketotifen; Leukotriene Antagonists; Loratadine; Piperazines; Quinolines; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Safety; Sulfides; Tablets; Terfenadine; Treatment Outcome | 2009 |
Ahh-choo! How to sneeze at allergies.
Topics: Adrenal Cortex Hormones; Cetirizine; Diphenhydramine; Health Behavior; Health Care Surveys; Histamine Antagonists; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Nasal Decongestants; Nonprescription Drugs; Prescription Drugs; Pseudoephedrine; Rhinitis, Allergic, Seasonal | 2010 |
Positive basophil activation test result in a patient with acute urticaria induced by cetirizine and desloratadine.
Topics: Adult; Basophils; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Urticaria | 2011 |
Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response.
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Taiwan; Treatment Outcome; Urticaria; Young Adult | 2011 |
The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cetirizine; Chromatography, High Pressure Liquid; Drug Interactions; Histamine H1 Antagonists; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Loratadine; Mass Spectrometry; Permeability; Terfenadine | 2012 |
Effects of oral intake of cetirizine HCl and desloratadine molecules on the middle ear mucosa: an experimental animal study.
Topics: Administration, Oral; Animals; Cetirizine; Ear, Middle; Edema; Histamine H1 Antagonists, Non-Sedating; Hyperemia; Loratadine; Mucous Membrane; Rats; Rats, Sprague-Dawley; Tympanic Membrane | 2014 |
Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nerve Growth Factor; Neuropeptide Y; Neuropeptides; Stem Cell Factor; Substance P; Urticaria; Vasoactive Intestinal Peptide; Young Adult | 2014 |
Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.
Topics: Acetates; Adolescent; Adult; Cetirizine; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Photosensitivity Disorders; Quinolines; Remission Induction; Remission, Spontaneous; Severity of Illness Index; Sulfides; Sunlight; Terfenadine; Ultraviolet Rays; Urticaria; Young Adult | 2015 |
BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.
Topics: beta-Arrestin 2; Binding, Competitive; Bioluminescence Resonance Energy Transfer Techniques; Cetirizine; Dose-Response Relationship, Drug; HEK293 Cells; Histamine; Histamine Agonists; Histamine H1 Antagonists, Non-Sedating; Humans; Kinetics; Ligands; Loratadine; Luciferases, Firefly; Models, Biological; NFATC Transcription Factors; Promoter Regions, Genetic; Protein Binding; Radioligand Assay; Receptors, Histamine H1; Recombinant Fusion Proteins | 2016 |
Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Cetirizine; Child; Child Mortality; Child, Preschool; Chlorpheniramine; Databases, Factual; Diphenhydramine; Epilepsy; Female; Histamine H1 Antagonists; Humans; Infant; Infant, Newborn; Loratadine; Male; Pharmacovigilance; Stevens-Johnson Syndrome; World Health Organization | 2017 |
Safe and effective intradermal influenza vaccine desensitization for delayed influenza vaccine allergy.
Topics: Adolescent; Anti-Allergic Agents; Cetirizine; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Humans; Influenza Vaccines; Influenza, Human; Injections, Intradermal; Injections, Intramuscular; Loratadine; Male; Treatment Outcome | 2018 |
Real-life experience in the treatment of solar urticaria: retrospective cohort study.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cohort Studies; Cyclopropanes; Disease Management; Female; Histamine Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Omalizumab; Photosensitivity Disorders; Quinolines; Retrospective Studies; Sulfides; Terfenadine; Urticaria; Young Adult | 2019 |
Rapid and sensitive method for simultaneous determination of citalopram with antihistamines by liquid chromatography.
Topics: Cetirizine; Chromatography, High Pressure Liquid; Citalopram; Humans; Loratadine; Reproducibility of Results | 2021 |
Analysis of degradation and pathways of three common antihistamine drugs by NaClO, UV, and UV-NaClO methods.
Topics: Cetirizine; Histamine Antagonists; Humans; Kinetics; Loratadine; Photolysis; Ultraviolet Rays; Water; Water Pollutants, Chemical; Water Purification | 2022 |